Pulmonary function, bronchial reactivity, and epithelial permeability are response phenotypes to ozone and develop differentially in healthy humans

Journal of Applied Physiology

Volumn 111, Issue 3, 2011, Pages 679-687

  Que, Loretta G ^a   Stiles, Jane V ^a   Sundy, John S ^a   Foster, W Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOCONSTRICTING AGENT; DIAGNOSTIC AGENT; METHACHOLINE CHLORIDE; OZONE; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BRONCHOSPASM; BRONCHUS; BRONCHUS HYPERREACTIVITY; CAUCASIAN; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; GROWTH, DEVELOPMENT AND AGING; HUMAN; INHALATION TEST; LUNG; MALE; METABOLISM; PATHOPHYSIOLOGY; PERMEABILITY; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT MUCOSA; SEX DIFFERENCE; STATISTICAL MODEL; TIME; UNITED STATES; VITAL CAPACITY;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; CROSS-OVER STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INHALATION EXPOSURE; LINEAR MODELS; LUNG; MALE; METHACHOLINE CHLORIDE; NORTH CAROLINA; OZONE; PERMEABILITY; PHENOTYPE; RADIOPHARMACEUTICALS; RESPIRATORY MUCOSA; SEX FACTORS; TECHNETIUM TC 99M PENTETATE; TIME FACTORS; VITAL CAPACITY; YOUNG ADULT;

EID: 80053001244     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00337.2011     Document Type: Article

References (52)

1. American Thoracic Society. Committee of the Assembly on Environmental, and Occupational Health. What constitutes an adverse health effect of air pollution? Am J Respir Crit Care Med 161: 665-73, 2000.
2. Aris RM, Tager I, Christian D, Kelly T, Balmes JR. Methacholine responsiveness is not associated with O3-induced decreases in FEV1. Chest 107: 621-628, 1995.
3. Arjomandi M, Witten A, Abbritti E, Reintjes K, Schmidlin I, Zhai W, Solomon C, Balmes J. Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways. Am J Respir Crit Care Med 172: 427-432, 2005. (Pubitemid 41117387)
4. Balmes JR, Chen LL, Scannnel C, Tager I, Christian D, Hearne PQ, Kelly T, Aris RM. Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med 153: 904-909, 1996. (Pubitemid 26081637)
5. Beckett WS, McDonnell WF, Horstman DH, House DE. Role of the parasympathetic nervous system in acute lung response to ozone. J Appl Physiol 59: 1879-1885, 1985. (Pubitemid 16158270)
6. Billinghurst MW. Chromatographic quality control of 99mTc-labeled compounds. J Nucl Med 14: 793-797, 1973.
7. Boezen M, Schouten J, Rijcken B, Vonk J, Gerritsen J, van der Zee S, Hoek G, Brunedreef B, Postma D. Peak expiratory flow variability, bronchial responsiveness, and susceptibility to ambient air pollution in adults. Am J Respir Crit Care Med 158: 1848-1854, 1998. (Pubitemid 29008824)
8. Bosson J, Barath S, Pourazar J, Behndig AF, Sandstrom T, Blomberg A, Adelroth E. Diesel exhaust exposure enhances the ozone-induced airway inflammation in healthy humans. Eur Respir J 31: 1234-1240, 2008.
9. Corradi M, Alinovi R, Goldoni M, Vettori MV, Folesani G, Mozzoni P, Cavassini S, Bergamaschi E, Mutti A. Biomarkers of oxidative stress after controlled human exposure to ozone. Toxicol Lett 134: 219-225, 2002. (Pubitemid 35007304)
10. Devlin RB, McDonnell WF, Becker S, Madden MC, McGee MP, Perez R, Hatch G, House DE, Koren HS. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 3 hr: a comparison of mediators found in bronchoalvoelar lavage fluid 1 and 18 h after exposure. Toxicol Appl Pharmacol 138: 176-185, 1996.
11. Drazen JM, Beier DR. Genetics of air pollution. Nat Genet 17: 365-366, 1997.
12. Eggleston PA, Buckley TJ, Breysse PN, Wills-Karp M, Kleeberger SR, Jaakkola JJ. Environment and asthma in US inner cities. Environ Health Perspect 107, Suppl 3: 439-450, 1999.
13. Folinsbee LJ, Horstman DH, Kehrl HR, Harder S, Abdul-Salaam S, Ives PJ. Respiratory responses to repeated prolonged exposure to 0.12 ppm ozone. Am J Respir Crit Care Med 149: 98-105, 1994. (Pubitemid 24066103)
14. Foster WM, Brown R, Macri K, Mitchell CS. Bronchial reactivity of healthy subjects: 18-20 h postexposure to ozone. J Appl Physiol 89: 1804-1810, 2000.
15. Foster WM, Freed AN. Regional clearance of solute from peripheral airway epithelia: recovery after sublobar exposure to ozone. J Appl Physiol 86: 641-646, 1999. (Pubitemid 29075819)
16. Foster WM, Silver JA, Groth ML. Exposure to ozone alters function and particle dosimetry in the human lung. J Appl Physiol 75: 1938-1945, 1993. (Pubitemid 23352360)
17. Foster WM, Stetkiewicz P. Regional clearance of solute from the respiratory epithelia 18-20 h postexposure to ozone. J Appl Physiol 81: 1143-1149, 1996. (Pubitemid 26309120)
18. Foster WM, Stetkiewicz PA, Freed AN. Retention of soluble 99mTc- DTPA in the human lung: 24-h postdeposition. J Appl Physiol 82: 1378-1382, 1997. (Pubitemid 27172343)
19. Foster WM, Wills-Karp M, Tankersley CG, Chen X, Paquette NC. Bloodborne markers in humans during multi-day exposure to ozone. J Appl Physiol 81: 794-800, 1996. (Pubitemid 26303233)
20. Gambone LM, Ebon CL, Fryer AD. Ozone-induced loss of neuronal M2 muscarinic receptor function is prevented by cyclophosphamide. J Appl Physiol 81: 794-800, 1996.
21. Holz O, Jorres RA, Timm P, Mucke M, Richter K, Koschyk S, Magnussen H. Ozone-induced airway inflammatory changes differ between individuals and are reproducible. Am J Respir Crit Care Med 159: 776-784, 1999. (Pubitemid 29137773)
22. Holtzman MJ, Cunningham JH, Sheller JR, Irsigler GB, Nadel JA, Boushey HA. Effect of ozone on bronchial reactivity in atopic and nonatopic subjects. Am Rev Respir Dis 120: 1059-1067, 1979. (Pubitemid 10218493)
23. Horstman DH, Folinsbee LJ, Ives PJ, Abdul-Salaam S, McDonnell WF. Ozone concentration and pulmonary response relationships for 6.6 h-hour exposures with five hours of moderate exercise to 008, 010, and 012 ppm. Am Rev Respir Dis 142: 1158-1163, 1990. (Pubitemid 20384380)
24. Hu SC, Ben-Jebria Ultman JS. Longitudinal distribution of ozone absorption in the lung: effects of respiratory flow. J Appl Physiol 77: 574-583, 1994.
25. Hulsmann AR, Raatgeep HR, Den Hollander JC, Stijnen T, Saxema PR, Kerrebijn KF, De Jongste JC. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med 149: 519-525, 1994. (Pubitemid 24069005)
26. Illowite JS, Bennett WD, Sheetz MS, Groth ML, Nierman DM. Permeability of the bronchial mucosa to 99mTc-DTPA in asthma. Am Rev Respir Dis 139: 1139-1143, 1989. (Pubitemid 19139834)
27. Jones JG, Royston D, Minty BD. Changes in alveolar-capillary barrier function in animals and humans. Am Rev Respir Dis 127: S51-59, 1983. (Pubitemid 13103649)
28. Kinney PL, Nilsen DM, Lippmann M, Brescia M, Gordon T, McGovern T, El Fawal H, Devlin RB, Rom WN. Biomarkers of lung inflammation in recreational joggers exposed to ozone. Am J Respir Crit Care Med 154: 1430-1435, 1996. (Pubitemid 26391193)
29. Koren HS, Devlin RB, Graham DE, Mannn R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnell WF, Bromberg PA. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 139: 401-415, 1989.
30. Leikauf GD, Zhao Q, Zhou S, Santrock J. Activation of eicosanoid metabolism in human airway epithelial cells by ozonolysis products of membrane fatty acids. Health Effects Institute, Report #71: 1-26, 1995.
31. Linn WS, Avol EL, Shamoo DA, Peng RC, Valencia LM, Little DE, Hackney JD. Repeated laboratory ozone exposures of volunteer Los Angeles residents: an apparent seasonal variation in response. Toxicol Ind Health 4: 505-520, 1988. (Pubitemid 18268465)
32. Maynard R. Key airborne pollutants-impact on health. Sci Total Environ 334-335: 9-13, 2004.
33. McCunney RJ. Asthma, genes, and air pollution. J Occup Environ Med 47: 1285-1291, 2005. (Pubitemid 41813037)
34. McDonnell WF, Horstman DH, Abdul-Salaam S, House DE. Reproducibility of individual responses to ozone exposure. Am Rev Respir Dis 131: 36-40, 1985. (Pubitemid 15161960)
35. Meignan M, Rosso J, Leveau J, Katz A, Cinotti L, Madelaine G, Galle P. Exercise increases lung clearance of inhaled technetium-99m DTPA. J Nucl Med 27: 274-280, 1986. (Pubitemid 17024874)
36. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine: an approach suitable for population studies. Am Rev Respir Dis 136: 1412-1417, 1987. (Pubitemid 18030275)
37. Passannante AN, Hazucha MJ, Bromberg PA, Seal E, Folinsbee L, Koch G. Nociceptive mechanisms modulate ozone-induced human lung function decrements. J Appl Physiol 85: 1863-1870, 1998. (Pubitemid 28516423)
38. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 19: 935-941, 1995.
39. Romieu I, Menesses F, Ruiz S, Huerta J, Sienra JJ, White M, Etzel R, Hernandez M. Effects of intermittent ozone exposure on peak expiratory flow and respiratory symptoms among asthmatic children in Mexico City. Arch Environ Health 52: 368-376, 1997. (Pubitemid 28133633)
40. Schelegle ES, Eldridge MW, Cross CE, Walby WF, Adams WC. Differential effects of airway anesthesia on ozone-induced pulmonary responses in human subjects. Am J Respir Crit Care Med 163: 1121-1127, 2001. (Pubitemid 32378448)
41. Schwartz J, Schindler C, Zemp E, Perruchoud AP, Zellweger JP, Wuthrich B, Leuenberger P, Ackermann-Liebrich U. Predictors of methacholine responsivneness in a general population. Chest 122: 812-820, 2002.
42. Seal E, McDonnell WF, House DE, Salaam SA, Dewitt PJ, Butler SO, Green J, Raggio L. The pulmonary response of white and black adults to six concentrations of ozone. Am Rev Respir Dis 147: 804-810, 1993. (Pubitemid 23093799)
43. Seltzer J, Bigby BG, Stulbarg M, Holtzman MJ, Nadel JA, Ueki IF, Leikauf GD, Goetzl EJ, Boushey HA. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 60: 1321-1326, 1986. (Pubitemid 16028433)
44. Sexton KG, Jeffries HE, Jang M, Kamens RM, Doyle M, Voivu I. Photochemical products in urban mixtures enhance inflammatory responses in lung cells. Inhal Toxicol 16, Suppl 1: 107-114, 2004. (Pubitemid 38923907)
45. Tashkin DP, Altose MD, Bleecker ER, Connett JE, Kanner RE, Lee WW, Wise R. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am Rev Respir Dis 145: 301-310, 1992.
46. Taylor RG, Agnew JE, Francis RA, Pavia D, Clarke SW. Respiratory epithelial permeability is unrelated to bronchial reactivity and smallairway function in young smokers and nonsmokers. Eur Respir J 1: 319-323, 1988.
47. Teisanu RM, Chen H, Matsumoto K, McQualter JL, Potts FosterWM E, Bertoncello I, Stripp BR. Functional analysis of two distinct bronchiolar progenitors during lung injury and repair. Am J Respir Crit Care Med 44: 794-803, 2011.
48. Van de Graaf EA, Out TA, Roos CM, Jansen HM. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 143: 362-368, 1991.
49. Weinmann GC, WSeidenbach-Gerbase M, Foster Wm Zacur H, Frank R. Evidence for ozone-induced small-airway dysfunction: lack of menstrual-cycle and gender effects. Am J Respir Crit Care Med 152: 988-996, 1995.
50. Wilson AM, Salloway JC, Wake CP, Kelly T. Air pollution and the demand for hospital services: a review. Environ Int 30: 1109-1118, 2004. (Pubitemid 39186139)
51. Zhou S, Potts EN, Cuttitta F, Foster WM, Sunday ME. Gastrinreleasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma. Proc Natl Acad Sci USA 108: 2100-2105, 2011.
52. Yamaya M, Sekizawa K, Masuda T, Morkawa M, Sawai T, Sasaki H. Oxidants affect permeability and repair of the cultured human tracheal epithelium. Am J Physiol Lung Cell Mol Physiol 268: L284-L293, 1995.